Walking Estimated Limitation Calculated by History - Study 2 (WELCH-2)

This study is currently recruiting participants.
Verified September 2012 by University Hospital, Angers
Sponsor:
Information provided by (Responsible Party):
University Hospital, Angers
ClinicalTrials.gov Identifier:
NCT01424020
First received: August 23, 2011
Last updated: September 29, 2012
Last verified: September 2012

August 23, 2011
September 29, 2012
September 2011
November 2013   (final data collection date for primary outcome measure)
Proportion of questionnaires with errors after self completion [ Time Frame: 1 day ] [ Designated as safety issue: No ]
Analysis of first inclusion only in patients that are included multiple times over the study period. Predetermined score for the WELCH questionnaire answers [(4 items); (4 additions & 1 multiplication)] and WIQ... estimation of the percentage of errors with 95% confidence interval. Comparison of the two percentages
Proportion of questionnaires with errors after self completion [ Time Frame: 1 day ] [ Designated as safety issue: No ]
Analysis of first inclusion only in patients that are included multiple times over the study period. Predetermined score for the WELCH questionnaire answers [(4 questions); (4 additions & 1 multiplication)]and WIQ... estimation of the percentage of errors with 95% confidence interval. Comparison of the two percentages
Complete list of historical versions of study NCT01424020 on ClinicalTrials.gov Archive Site
  • Correlation with ankle brachial index (ABI) [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    Analysis of first inclusion only in patients that are included multiple times over the study period. Calculation of questionnaire scores from predetermined methods and analysis of the coefficient of determination and coefficient of correlation to minimal ABI
  • Correlation with treadmill result [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    Analysis of first inclusion only in patients that are included multiple times over the study period.Calculation of questionnaires score from predetermined methods and analysis of the coefficient of determination and coefficient of correlation to maximal walking distance on treadmill, in the subgroup of patients that have a routine treadmill scheduled during the visit.
  • Facility of the scoring of the questionnaires [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    Proportion of WELCH scores calculated by physician and comparison to the proportion of WIQ score calculated by physicians as a estimation of the facility to calculate the score by mental calculation in routine
  • Reliability of the questionnaire [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]
    Comparison of the scores of the WELCH in the patients that may be seens within 3 weeks of their first inclusion, for any reasons, (e.i. seen first for a doppler and two weeks later for a treadmill test)over the study period. Analysis of the reliability through the coefficient of variation of the score.
  • sensitivity of the WELCH to changes [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Comparison of the scores of the WELCH in the patients that may be seens within 1 year from their first inclusion, for any reasons, (e.i. seen follow up of their disease)over the study period. Analysis of the changes of the score to changes of the ABI. Analysis of the changes of the score to changes in maximal walking distance if available.
Same as current
Not Provided
Not Provided
 
Walking Estimated Limitation Calculated by History - Study 2
Estimation de la capacité Fonctionnelle à la Marche Par Questionnaire Clinique Chez Les Patients adressés Pour Bilan artériel Des Membres inférieurs

The purpose of this study is to test and validate a new questionnaire in order to get a "walking estimated limitation calculated by history (WELCH) in patients referred for vascular investigations.

Two questionnaires the WELCH and the "walking impairment questionnaire" (WIQ) are submitted to patients referred for vascular investigations for suspêcted peripheral arterial disease (PAD). Comparison of score to hemodynamic parameters (first goal) or maximal walking distance (MWD) on treadmill (secondary goal). Scoring of the WIQ is performed according to references. Scoring of the WELCH has been submitted for copyright protection (involves a series of 4 additions a subtraction and a single multiplication)

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients referred for arterial vascular investigation regardless of whether they are prooved for peripheral arterial disease, or not.

Peripheral Artery Disease
Other: Questionnaire
Self completed questionnaire, Supervised by the physician Ankle brachial index (ABI) calculation Maximal walking distance (MWD) on treadmill or over the 6 minutes walking test (when available)
Other Names:
  • Walking impairment questionnaire (WIQ)
  • Walking estimated limitation calculated by history (WELCH)
suspected PAD patients
Patients suspected of peripheral artery disease and, as such, referred for a vascular investigations
Intervention: Other: Questionnaire
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
800
November 2013
November 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • French Native language
  • 18 years old or older
  • Signed consent
  • Covered by the French social care system

Exclusion Criteria:

  • Unable to participate for administrative reasons
  • Psychiatric troubles
  • Pain at rest or critical limb ischemia
  • Unable to walk (ex: wheelchair subjects)

Note: previous inclusion in the protocole is note an exclusion criterion for a new participation.

Both
18 Years and older
Yes
Contact: Pierre Abraham, MD; PhD 33 (0) 2 41 35 36 89 piabraham@chu-angers.fr
Contact: Johann Marchand, MD welch@gernigon.fr
France
 
NCT01424020
CHU-P 2011-06
No
University Hospital, Angers
University Hospital, Angers
Not Provided
Principal Investigator: Pierre ABRAHAM, MD; PhD University Hospital in Angers
University Hospital, Angers
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP